Vanessa Kennedy, MD

Title(s)Adjunct Instructor, Medicine
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford University HospitalInternal Medicine Residency06/2019
    Vanderbilt University School of MedicineMD05/2016
    Duke UniversityBS05/2010
    Collapse Awards and Honors
    Chan Zuckerberg Institute2021Physician-Scientist Fellow
    University of California San Francisco2020Rachel Perline Award
    American Society of Hematology2020Abstract Achievement Award
    American Society of Hematology2018  - 2019Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award
    American Society of Hematology2015Abstract Achievement Award
    Vanderbilt University School of Medicine2015Gold Humanism Honor Society

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Phase 1 Clinical Trial of NKTR-255 with CD19-22 CAR-T Cell Therapy for Refractory B-cell Acute Lymphoblastic Leukemia. Blood. 2024 Jul 05. Srinagesh HK, Jackson C, Shiraz P, Jeyakumar N, Hamilton MP, Egeler E, Mavroukakis S, Kuo A, Cancilla J, Sahaf B, Agarwal N, Kanegai AM, Kramer AM, Arai S, Bharadwaj S, Dahiya S, Hosoya H, Johnston LJ, Kennedy VE, Liedtke M, Lowsky R, Mikkilineni L, Negrin RS, Rezvani AR, Sidana S, Shizuru JA, Smith M, Weng WK, Feldman SA, Frank MJ, Lee Z, Tagliaferri M, Marcondes AMQ, Miklos DB, Mackall CL, Muffly L. PMID: 38968138.
      View in: PubMed   Mentions:    Fields:    
    2. Advancing Readership Needs of the Clinical Cancer Informatics Community. JCO Clin Cancer Inform. 2024 May; 8:e2400024. Kennedy VE, Bates BA, Rooney MK. PMID: 38718310.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry. Allergy. 2024 Apr 23. Niedoszytko M, Gorska A, Brockow K, Bonadonna P, Lange M, Kluin-Nelemans H, Oude-Elberink H, Sabato V, Shoumariyeh K, von Bubnoff D, Müller S, Illerhaus A, Doubek M, Angelova-Fischer I, Hermine O, Arock M, Elena C, Malcovati L, Yavuz AS, Schug TD, Fortina AB, Judit V, Gotlib J, Panse J, Vucinic V, Reiter A, Schwaab J, Triggiani M, Mattsson M, Breynaert C, Romantowski J, Zanotti R, Olivieri E, Zink A, van de Ven A, Stefan A, Barete S, Caroppo F, Perkins C, Kennedy V, Christen D, Jawhar M, Luebke J, Parente R, Levedahl K, Hadzijusufovic E, Hartmann K, Nedoszytko B, Sperr WR, Valent P. PMID: 38651829.
      View in: PubMed   Mentions:    Fields:    
    4. Long-Term Clinical Outcomes and B Cell Immune Reconstitution Following Allo-HCT With Prophylactic, Post-Transplant Rituximab. Transplant Cell Ther. 2024 May; 30(5):518.e1-518.e13. Kennedy VE, Sahaf B, Wu F, Ehlinger ZJ, Arai S, Miklos DB. PMID: 38458479.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    5. Monoclonal Gammopathy of Anemic Significance? Resolution of Pure Red Cell Aplasia With Daratumumab-Based Therapy. Am J Med. 2024 Jul; 137(7):589-591. Khan O, Prakash S, Chung A, Wong SW, Kennedy VE. PMID: 38401677.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia. Leuk Lymphoma. 2024 Jan; 65(1):69-77. Gaut D, Oliai C, Boiarsky J, Zhang S, Salhotra A, Azenkot T, Kennedy VE, Khanna V, Olmedo Gutierrez K, Shukla N, Moskoff B, Park G, Afkhami M, Patel A, Jeyakumar D, Mannis G, Logan AC, Jonas BA, Schiller G. PMID: 37801340.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia. Haematologica. 2023 Dec 28. Wintering A, Hecht A, Meyer J, Wong EB, Hübner J, Abelson S, Feldman K, Kennedy VE, Peretz CAC, French DL, Maguire JA, Jobaliya C, Vasquez MR, Desai S, Dulman R, Nemecek E, Haines H, Hammad M, El Haddad A, Kogan SC, Abdullaev Z, Chehab FF, Tasian SK, Smith CC, Loh ML, Stieglitz E. PMID: 38152053.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    8. FLT3 targeting in the modern era: from clonal selection to combination therapies. Int J Hematol. 2023 Dec 19. Kennedy VE, Smith CC. PMID: 38112995.
      View in: PubMed   Mentions:    Fields:    
    9. Multiomic Single Cell Sequencing Identifies Stemlike Nature of Mixed Phenotype Acute Leukemia and Provides Novel Risk Stratification. bioRxiv. 2023 May 18. Peretz CAC, Kennedy VE, Walia A, Delley CL, Koh A, Tran E, Clark IC, Hayford CE, D'Amato C, Xue Y, Fontanez KM, Roy R, Logan AC, Perl AE, Abate A, Olshen A, Smith CC. PMID: 37292835; PMCID: PMC10245585.
      View in: PubMed   Mentions:
    10. Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry. Blood Adv. 2023 05 09; 7(9):1713-1724. Kennedy VE, Perkins C, Reiter A, Jawhar M, Lübke J, Kluin-Nelemans HC, Shomali W, Langford C, Abuel J, Hermine O, Niedoszytko M, Gorska A, Mital A, Bonadonna P, Zanotti R, Tanasi I, Mattsson M, Hagglund H, Triggiani M, Yavuz AS, Panse J, Christen D, Heizmann M, Shoumariyeh K, Müller S, Elena C, Malcovati L, Fiorelli N, Wortmann F, Vucinic V, Brockow K, Fokoloros C, Papageorgiou SG, Breynaert C, Bullens D, Doubek M, Ilerhaus A, Angelova-Fischer I, Solomianyi O, Várkonyi J, Sabato V, Rüfer A, Schug TD, Hermans MAW, Fortina AB, Caroppo F, Bumbea H, Gulen T, Hartmann K, Elberink HO, Schwaab J, Arock M, Valent P, Sperr WR, Gotlib J. PMID: 36094848; PMCID: PMC10182174.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    11. Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Systemic Light Chain Amyloidosis. Curr Probl Cancer. 2023 06; 47(3):100953. Kennedy VE, Natsuhara K, Maringanti SA, Shah ND, Arora S, Wolf J, Martin TG, Aras MA, Chung A, Wong SW. PMID: 36807996.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy. Blood Adv. 2022 04 12; 6(7):2045-2054. Kambhampati S, Sheng Y, Huang CY, Bylsma S, Lo M, Kennedy V, Natsuhara K, Martin T, Wolf J, Shah N, Wong SW. PMID: 34543400; PMCID: PMC9006279.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    13. Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia. Am J Hematol. 2022 06 01; 97(6):E191-E194. Kennedy VE, Hui G, Azenkot T, Gaut D, Wieduwilt MJ, Oliai C, Jonas BA, Mittal V, Logan AC, Muffly LS, Mannis GN. PMID: 35266185.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    14. Geriatric assessment in adults age 50 years and older undergoing autologous hematopoietic cell transplantation for lymphoma. J Geriatr Oncol. 2022 06; 13(5):644-647. Kennedy VE, Huang CY, Kaplan LD, Andreadis C, Ai WZ, Olin RL. PMID: 35256304.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent. Br J Haematol. 2022 04; 197(1):63-70. On S, Rath CG, Lan M, Wu B, Lau KM, Cheung E, Alegria W, Young R, Tan M, Kim C, Phun J, Patel N, Mannis G, Logan AC, Kennedy V, Goodman A, Taplitz RA, Young PA, Wen R, Saunders IM. PMID: 35174480.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    16. Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma. Blood Adv. 2021 12 14; 5(23):5344-5348. Kennedy VE, Wong C, Huang CY, Kambhampati S, Wolf J, Martin TG, Shah N, Wong SW. PMID: 34644387; PMCID: PMC9153014.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    17. VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis. Blood Adv. 2021 11 23; 5(22):4662-4665. Kennedy VE, Wong CC, Hong JM, Peng T, Brondfield S, Reilly LM, Cornett P, Leavitt AD. PMID: 34587255; PMCID: PMC8483979.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    18. Haematopoietic stem-cell transplantation in older adults: geriatric assessment, donor considerations, and optimisation of care. Lancet Haematol. 2021 Nov; 8(11):e853-e861. Kennedy VE, Olin RL. PMID: 34624239.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    19. Frontline treatment patterns and outcomes among older adults with acute myeloid leukemia: A population-based analysis in the modern era. Cancer. 2022 01 01; 128(1):139-149. Kennedy VE, Keegan THM, Li Q, Maguire FB, Muffly LS. PMID: 34436782.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. Strongyloides Hyperinfection After Immunosuppression in an Immigrant From El Salvador: A Case for Early Diagnosis and Treatment. J Clin Rheumatol. 2021 Jun 01; 27(4):e128-e131. Hoppenfeld MS, Kennedy V, Sheth K, Chang A, Nelson J, Fairchild RM. PMID: 30074914.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    21. Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma. Transplant Cell Ther. 2021 06; 27(6):477.e1-477.e7. Banerjee R, Marsal J, Huang CY, Lo M, Kambhampati S, Kennedy VE, Arora S, Wolf JL, Martin TG, Wong SW, Shah N. PMID: 33831353.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    22. A Case of EBV-Negative Aggressive NK-cell Leukemia: Use of Next-Generation Sequencing in Demystifying a Diagnostic Dilemma and Guiding Clinical Care. Clin Lymphoma Myeloma Leuk. 2021 07; 21(7):e583-e587. Kennedy VE, Ruiz-Cordero R, Jangam D, Wen KW, Dunavin N, Ohgami RS, Bhargava P, Ai W, Fakhri B. PMID: 33814335.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    23. Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis. Theranostics. 2021; 11(1):292-303. Kluin-Nelemans HC, Jawhar M, Reiter A, van Anrooij B, Gotlib J, Hartmann K, Illerhaus A, Oude Elberink HNG, Gorska A, Niedoszytko M, Lange M, Scaffidi L, Zanotti R, Bonadonna P, Perkins C, Elena C, Malcovati L, Shoumariyeh K, von Bubnoff N, Müller S, Triggiani M, Parente R, Schwaab J, Kundi M, Fortina AB, Caroppo F, Brockow K, Zink A, Fuchs D, Angelova-Fischer I, Yavuz AS, Doubek M, Mattsson M, Hagglund H, Panse J, Simonowski A, Sabato V, Schug T, Jentzsch M, Breynaert C, Várkonyi J, Kennedy V, Hermine O, Rossignol J, Arock M, Valent P, Sperr WR. PMID: 33391475; PMCID: PMC7681091.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    24. FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies. Front Oncol. 2020; 10:612880. Kennedy VE, Smith CC. PMID: 33425766; PMCID: PMC7787101.
      View in: PubMed   Mentions: 52  
    25. Marked Hyperbilirubinemia-Silent No More! Am J Med. 2020 12; 133(12):e733-e734. Kennedy VE, Leavitt AD, Cornett P. PMID: 32473870.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Late Effects in Survivors of Adolescent and Young Adult Acute Lymphoblastic Leukemia. JNCI Cancer Spectr. 2020 Aug; 4(4):pkaa025. Muffly L, Maguire FB, Li Q, Kennedy V, Keegan TH. PMID: 32704618; PMCID: PMC7368465.
      View in: PubMed   Mentions: 12     Fields:    
    27. Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry. Leukemia. 2020 04; 34(4):1090-1101. Kluin-Nelemans HC, Reiter A, Illerhaus A, van Anrooij B, Hartmann K, Span LFR, Gorska A, Niedoszytko M, Lange M, Scaffidi L, Zanotti R, Bonadonna P, Perkins C, Elena C, Malcovati L, Shoumariyeh K, von Bubnoff N, Parente R, Triggiani M, Schwaab J, Jawhar M, Caroppo F, Fortina AB, Brockow K, Zink A, Fuchs D, Kilbertus A, Yavuz AS, Doubek M, Mattsson M, Hagglund H, Panse J, Sabato V, Aberer E, Niederwieser D, Breynaert C, Várkonyi J, Kennedy V, Lortholary O, Jakob T, Hermine O, Rossignol J, Arock M, Gotlib J, Valent P, Sperr WR. PMID: 31740811; PMCID: PMC7115841.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    28. MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis. J Clin Oncol. 2019 11 01; 37(31):2846-2856. Jawhar M, Schwaab J, Álvarez-Twose I, Shoumariyeh K, Naumann N, Lübke J, Perkins C, Muñoz-González JI, Meggendorfer M, Kennedy V, Metzgeroth G, Fabarius A, Pfeifer D, Sotlar K, Horny HP, von Bubnoff N, Haferlach T, Cross NCP, Hofmann WK, Sperr WR, García-Montero AC, Valent P, Gotlib J, Orfao A, Reiter A. PMID: 31509472; PMCID: PMC6823885.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    29. Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort. Blood Adv. 2019 08 27; 3(16):2454-2464. Spinner MA, Kennedy VE, Tamaresis JS, Lavori PW, Arai S, Johnston LJ, Meyer EH, Miklos DB, Muffly LS, Negrin RS, Rezvani AR, Shizuru JA, Weng WK, Hoppe RT, Strober S, Lowsky R. PMID: 31427277; PMCID: PMC6712526.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    30. Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience. Front Oncol. 2019; 9:623. Sheth V, Kennedy V, de Lavallade H, Mclornan D, Potter V, Engelhardt BG, Savani B, Chinratanalab W, Goodman S, Greer J, Kassim A, York S, Kenyon M, Gandhi S, Kulasekararaj A, Marsh J, Mufti G, Pagliuca A, Jagasia M, Raj K. PMID: 31355140; PMCID: PMC6636242.
      View in: PubMed   Mentions: 3  
    31. Assessment of older adult candidates for allogeneic hematopoietic cell transplantation: updates and remaining questions. Expert Rev Hematol. 2019 02; 12(2):99-106. Kennedy VE, Muffly LS. PMID: 30632411.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    32. The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives. J Allergy Clin Immunol Pract. 2019 01; 7(1):81-87. Valent P, Oude Elberink JNG, Gorska A, Lange M, Zanotti R, van Anrooij B, Bonifacio M, Bonadonna P, Gleixner KV, Hadzijusufovic E, Perkins C, Hartmann K, Illerhaus A, Merante S, Elena C, Shoumariyeh K, von Bubnoff N, Parente R, Triggiani M, Schwaab J, Jawhar M, Caroppo F, Fortina AB, Brockow K, Greul R, Yavuz AS, Doubek M, Mattsson M, Hagglund H, Panse J, Sabato V, Aberer E, Al-Ali HK, Morren MA, Varkonyi J, Zink A, Niedoszytko M, Niederwieser D, Malcovati L, Reiter A, Kennedy V, Gotlib J, Lortholary O, Hermine O, Arock M, Kluin-Nelemans H, Sperr WR, Study Group of the European Competence Network on Mastocytosis (ECNM). PMID: 30416055; PMCID: PMC7115815.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    33. Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count. Biol Blood Marrow Transplant. 2018 01; 24(1):150-155. Kennedy VE, Chen H, Savani BN, Greer J, Kassim AA, Engelhardt BG, Goodman S, Sengsayadeth S, Chinratanalab W, Jagasia M. PMID: 28864139.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    34. Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma. J Hematol Oncol. 2017 06 12; 10(1):117. Epperla N, Ahn KW, Ahmed S, Jagasia M, DiGilio A, Devine SM, Jaglowski S, Kennedy V, Rezvani AR, Smith SM, Sureda A, Fenske TS, Kharfan-Dabaja MA, Armand P, Hamadani M. PMID: 28606176; PMCID: PMC5469142.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    35. Defining the complex phenotype of severe systemic loxoscelism using a large electronic health record cohort. PLoS One. 2017; 12(4):e0174941. Robinson JR, Kennedy VE, Doss Y, Bastarache L, Denny J, Warner JL. PMID: 28422977; PMCID: PMC5396866.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    36. Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia. Biol Blood Marrow Transplant. 2017 Jul; 23(7):1117-1121. Hamilton BK, Rybicki L, Abounader D, Adekola K, Advani A, Aldoss I, Bachanova V, Bashey A, Brown S, DeLima M, Devine S, Flowers CR, Ganguly S, Jagasia M, Kennedy VE, Kim DDH, McGuirk J, Pullarkat V, Romee R, Sandhu K, Smith M, Ueda M, Viswabandya A, Vu K, Wall S, Zeichner SB, Perales MA, Majhail NS. PMID: 28396160; PMCID: PMC5549947.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    37. Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies. Biol Blood Marrow Transplant. 2016 10; 22(10):1801-1807. Kennedy VE, Savani BN, Greer JP, Kassim AA, Engelhardt BG, Goodman SA, Sengsayadeth S, Chinratanalab W, Jagasia M. PMID: 27377900.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    38. Does adherence to epilepsy quality measures correlate with reduced epilepsy-related adverse hospitalizations? A retrospective experience. Epilepsia. 2015 May; 56(5):e63-7. Ladner TR, Morgan CD, Pomerantz DJ, Kennedy VE, Azar N, Haas K, Lagrange A, Gallagher M, Singh P, Abou-Khalil BW, Arain AM. PMID: 25809720.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. Can you ask? We just did! Assessing sexual function and concerns in patients presenting for initial gynecologic oncology consultation. Gynecol Oncol. 2015 Apr; 137(1):119-24. Kennedy V, Abramsohn E, Makelarski J, Barber R, Wroblewski K, Tenney M, Lee NK, Yamada SD, Lindau ST. PMID: 25582823; PMCID: PMC4518539.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    40. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity. Am J Respir Crit Care Med. 2014 Mar 01; 189(5):556-66. Todd JL, Wang X, Sugimoto S, Kennedy VE, Zhang HL, Pavlisko EN, Kelly FL, Huang H, Kreisel D, Palmer SM, Gelman AE. PMID: 24471427; PMCID: PMC3977710.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    41. Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome. Am J Transplant. 2013 Mar; 13(3):552-61. Kennedy VE, Todd JL, Palmer SM. PMID: 23356456; PMCID: PMC3582805.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    42. Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantation. Am J Transplant. 2012 Nov; 12(11):3076-84. Kelly FL, Kennedy VE, Jain R, Sindhwani NS, Finlen Copeland CA, Snyder LD, Eu JP, Meltzer EB, Brockway BL, Pavlisko E, Stripp BR, Palmer SM. PMID: 22883104; PMCID: PMC3484196.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    Vanessa's Networks
    Concepts (190)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (39)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.